Cargando…

Pancreatitis-Associated Protein in Neonatal Screening for Cystic Fibrosis: Strengths and Weaknesses

There are currently four countries and one local region in Europe that use PAP in their newborn screening programme. The first country to employ PAP at a national level was the Netherlands, which started using IRT/PAP/DNA/EGA in 2011. Germany followed in 2016 with a slightly different IRT/PAP/DNA st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sommerburg, Olaf, Hammermann, Jutta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422993/ https://www.ncbi.nlm.nih.gov/pubmed/33073025 http://dx.doi.org/10.3390/ijns6020028

Ejemplares similares

Inquilinus limosus in Patients with Cystic Fibrosis, Germany
por: Wellinghausen, Nele, et al.
Publicado: (2005)

A Volatile and Dynamic Longitudinal Microbiome Is Associated With Less Reduction in Lung Function in Adolescents With Cystic Fibrosis
por: Metzger, Marisa I., et al.
Publicado: (2021)

Implementing a tracking system for confirmatory diagnostic results after positive newborn screening for cystic fibrosis—implications for process quality and patient care
por: Gramer, Gwendolyn, et al.
Publicado: (2020)

Effects of lumacaftor—ivacaftor therapy on cystic fibrosis transmembrane conductance regulator function in F508del homozygous patients with cystic fibrosis aged 2–11 years
por: Berges, Julian, et al.
Publicado: (2023)

Bicarbonate Transport in Cystic Fibrosis and Pancreatitis
por: Angyal, Dora, et al.
Publicado: (2021)

Neonatal Screening for Cystic Fibrosis in Hungary—First-Year Experiences
por: Xue, Andrea, et al.
Publicado: (2023)

Changes in Microbiome Dominance Are Associated With Declining Lung Function and Fluctuating Inflammation in People With Cystic Fibrosis
por: Frey, Dario L., et al.
Publicado: (2022)

Pancreatic Enzyme Replacement Therapy in Cystic Fibrosis
por: Freswick, Peter N., et al.
Publicado: (2022)

Supplementation with Red Palm Oil Increases β-Carotene and Vitamin A Blood Levels in Patients with Cystic Fibrosis
por: Sommerburg, Olaf, et al.
Publicado: (2015)

Comparison between Gibson–Cooke and Macroduct Methods in the Cystic Fibrosis Neonatal Screening Program and in Subjects Who Are Cystic Fibrosis Screen-Positive with an Inconclusive Diagnosis
por: Dolce, Daniela, et al.
Publicado: (2023)

TRACK-CF prospective cohort study: Understanding early cystic fibrosis lung disease
por: Steinke, Eva, et al.
Publicado: (2023)

Understanding the Pancreatic Islet Microenvironment in Cystic Fibrosis and the Extrinsic Pathways Leading to Cystic Fibrosis Related Diabetes
por: Al-Selwi, Yara, et al.
Publicado: (2021)

The strength of weak embodiment
por: Tirado, Carlos, et al.
Publicado: (2018)

Delayed release pancrelipase for the treatment of pancreatic exocrine insufficiency associated with cystic fibrosis
por: Baker, Susan S
Publicado: (2008)

Impact of exacerbations of cystic fibrosis on muscle strength
por: Burtin, Chris, et al.
Publicado: (2013)

Prenatal Diagnosis of Cystic Fibrosis and Hemophilia: Incidental Findings and Weak Points
por: Comegna, Marika, et al.
Publicado: (2019)

The Changing Face of Cystic Fibrosis and Its Implications for Screening
por: Naehrlich, Lutz
Publicado: (2020)

Inconclusive Diagnosis after Newborn Screening for Cystic Fibrosis
por: Munck, Anne
Publicado: (2020)

History of Newborn Screening for Cystic Fibrosis—The Early Years
por: Travert, Georges, et al.
Publicado: (2020)

Diagnostic and Communication Challenges in Cystic Fibrosis Newborn Screening
por: DeCelie-Germana, Joan Kathleen, et al.
Publicado: (2023)

Neonatal Bartter syndrome associated with ileal atresia and cystic fibrosis
por: Akuma, A. O., et al.
Publicado: (2013)

Increased Inflammatory Markers Detected in Nasal Lavage Correlate with Paranasal Sinus Abnormalities at MRI in Adolescent Patients with Cystic Fibrosis
por: Chung, Jaehi, et al.
Publicado: (2021)

Factors Associated with Worse Lung Function in Cystic Fibrosis Patients with Persistent Staphylococcus aureus
por: Junge, Sibylle, et al.
Publicado: (2016)

Cystic Fibrosis Screen Positive, Inconclusive Diagnosis Genotypes in the Cystic Fibrosis Registry
por: Thompson, Cassandra, et al.
Publicado: (2023)

Cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/cystic fibrosis screen positive, inconclusive diagnosis (CRMS/CFSPID)
por: Sinha, Aditi, et al.
Publicado: (2021)

Magnetic resonance imaging detects onset and association with lung disease severity of bronchial artery dilatation in cystic fibrosis
por: Leutz-Schmidt, Patricia, et al.
Publicado: (2023)

CFTR Modulator Therapy with Lumacaftor/Ivacaftor Alters Plasma Concentrations of Lipid-Soluble Vitamins A and E in Patients with Cystic Fibrosis
por: Sommerburg, Olaf, et al.
Publicado: (2021)

Newborn Screening for Cystic Fibrosis in Delaware
por: Shenoy, Ambika, et al.
Publicado: (2018)

Pancreatic Cystosis in Two Adolescents with Cystic Fibrosis
por: Hatziagorou, Elpis, et al.
Publicado: (2016)

Role of vitamin D in cystic fibrosis and non-cystic fibrosis bronchiectasis
por: Moustaki, Maria, et al.
Publicado: (2017)

Cystic Fibrosis
por: Gibson, Lewis E.
Publicado: (1969)

Cystic Fibrosis
por: Dodge, J A
Publicado: (1997)

The Role of Extended CFTR Gene Sequencing in Newborn Screening for Cystic Fibrosis
por: Bergougnoux, Anne, et al.
Publicado: (2020)

Strengths and weaknesses of pneumococcal conjugate vaccines
por: Micoli, Francesca, et al.
Publicado: (2023)

Animal Models for Influenza Research: Strengths and Weaknesses
por: Nguyen, Thi-Quyen, et al.
Publicado: (2021)

Protein biomarkers in cystic fibrosis research: where next?
por: Pattison, Sally H, et al.
Publicado: (2010)

The cost-effectiveness of neonatal screening for Cystic Fibrosis: an analysis of alternative scenarios using a decision model
por: Simpson, Neil, et al.
Publicado: (2005)

Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectives
por: Schmidt, Béla Z, et al.
Publicado: (2016)

Weakness as a strength
por: LeBrasseur, Nicole
Publicado: (2005)

Long-term effects of lumacaftor/ivacaftor on paranasal sinus abnormalities in children with cystic fibrosis detected with magnetic resonance imaging
por: Wucherpfennig, Lena, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_c3qgv6m5gc0bc88sbjvr01ors9